Skip Fleshman

Skip Fleshman is a partner at Asset Management Ventures who has invested in companies such as Proteus Digital Health, WellDoc, HealthTap, Evidation Health, Reify Health, Lark and Welkin. You can follow him on Twitter @skipfleshman and @amv.

Contributed: Trials and tribulations – the new world of decentralized trials
By  Skip Fleshman 11:19 am January 22, 2021
Asset Management Ventures' Skip Fleshman outlines COVID-19's impact on clinical trials and the resulting leap toward tech-enabled decentralized trials.
Five digital health trends investors are watching in 2017
By  Skip Fleshman 02:16 pm February 16, 2017

Editor's Pick

Trump unveils $500B 'Project Stargate' to build AI infrastructure in the U.S.
Q&A: Philips on game-changing innovation and responsible AI at JPM
Healthcare experts discuss AI oversight and innovation at BCG event
Q&A: GE HealthCare explores AI and healthcare innovations during JPM
Trump revokes Biden's executive order on responsible AI development
Q&A: Qventus announces $105M investment during JPM Healthcare Conference
MobiHealthNews: The latest news in digital health delivered daily to your inbox.
Thank you for subscribing!
Error! Something went wrong!

More Stories

Person sitting in a park while wearing an orange sweater with a hood
Irish company Neuromod scores $10.9M for tinnitus medical device
Photo of Gina Galanou Luchen, Scott Anderson
Q&A: AI is playing a pivotal role in health system pharmacy
Group of women
Axia Women's Health inks deal with payors in New Jersey, Pennsylvania
Executives meeting in a conference room
Syra Health reports $1.7M growth in population health unit in 2024
Healthcare professional with a tablet
Teladoc Health broadens connected care partnerships
Person grabbing their shoulder due to discomfort
Vori Health raises $53M for musculoskeletal care platform
Two surgeons operating on a body
Korean researchers develop AI to gauge surgery pain
A person checking their fitness tracker data on their mobile phone
Health2Sync eyes Taiwan IPO with $20M Series C fund